Usefulness umbilical cord blood transfusion in neonates

To study the effectiveness of umbilical cord blood transfusion in neonates at tertiary health care centre

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024701

Enrollment

100

Registered

2020-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P619- Perinatal hematological disorder,unspecified

Interventions

Intervention1: umblical cord whole blood.: those neonates requiring blood transfusion were transfused with umibilical cord blood Control Intervention1: Adult whole blood: those newborn requiring blood

Eligibility

Inclusion criteria

Inclusion criteria: 1. Neonates >34 week gestation admitted in NICU requiring Blood Transfusion & whose parents gave legal consent for the procedure.

Exclusion criteria

Exclusion criteria: 1.Patient who were not willing for the procedure. 2. Neonates who have earlier h/o blood transfusion. 3. Syndromic Neonates and those with Congenital Anomaly. 4. Neonates with hemolytic disease

Design outcomes

Primary

Measure	Time frame
mortality of subjects appearance of side effectsTimepoint: Appearance of side effects : at the time of tranfusion 1 hour after transfusion 2 hour after transfusion Mortality of subjects: at the time of discharge	—

Secondary

Measure	Time frame
usefulness of umblical cord blood transfusion in neonatal careTimepoint: from admission in nicu to discharge.	—

Countries

India

Contacts

Public ContactDr Deepak dwivedi

SS Medical College

shoaibbegmirza@gmail.com7869918636

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026